Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J DeAngelo

Showing results (91-100 of 320) with videos related to

Pageof 32
Sort By:
Cell Reports|December 22, 2015
RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic InstabilityEdwin Chen, Jong Sook Ahn, David B Sykes, et al.
Haematologica|December 1, 2022
Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysisShai Shimony, Alon Rozental, Jan P Bewersdorf, et al.
Cancer|October 27, 2020
Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphomaGautam Borthakur, Giovanni Martinelli, Emmanuel Raffoux, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2008
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804Richard M Stone, Kathleen A Donohue, Wendy Stock, et al.
Current Medical Research and Opinion|April 29, 2011
Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trialsJames E Signorovitch, Eric Q Wu, Keith A Betts, et al.
Journal of Geriatric Oncology|June 16, 2015
Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adultsK Rebecca Fega, Gregory A Abel, Gabriela Motyckova, et al.
Oncotarget|March 10, 2016
Insulin receptor substrate 1 is a substrate of the Pim protein kinasesJin H Song, Sathish K R Padi, Libia A Luevano, et al.
Blood Reviews|March 16, 2024
Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?Geoffrey L Uy, Daniel J DeAngelo, Jay N Lozier, et al.
Leukemia|March 28, 2024
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patientsShai Shimony, Jacqueline S Garcia, Julia Keating, et al.
American Journal of Hematology|August 19, 2011
Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshopTariq I Mughal, Jerald P Radich, Richard A Van Etten, et al.
Pageof 32

Showing results (91-100 of 320) with videos related to

Sort By:
Pageof 32
Cell Reports|December 22, 2015
RECQL5 Suppresses Oncogenic JAK2-Induced Replication Stress and Genomic InstabilityEdwin Chen, Jong Sook Ahn, David B Sykes, et al.
Haematologica|December 1, 2022
Investigational venetoclax combination therapy in acute myeloid leukemia - a systematic review and meta-analysisShai Shimony, Alon Rozental, Jan P Bewersdorf, et al.
Cancer|October 27, 2020
Phase 1 study to evaluate Crenigacestat (LY3039478) in combination with dexamethasone in patients with T-cell acute lymphoblastic leukemia and lymphomaGautam Borthakur, Giovanni Martinelli, Emmanuel Raffoux, et al.
Cancer Chemotherapy and Pharmacology|August 2, 2008
A phase II study of continuous infusion homoharringtonine and cytarabine in newly diagnosed patients with chronic myeloid leukemia: CALGB study 19804Richard M Stone, Kathleen A Donohue, Wendy Stock, et al.
Current Medical Research and Opinion|April 29, 2011
Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trialsJames E Signorovitch, Eric Q Wu, Keith A Betts, et al.
Journal of Geriatric Oncology|June 16, 2015
Non-hematologic predictors of mortality improve the prognostic value of the international prognostic scoring system for MDS in older adultsK Rebecca Fega, Gregory A Abel, Gabriela Motyckova, et al.
Oncotarget|March 10, 2016
Insulin receptor substrate 1 is a substrate of the Pim protein kinasesJin H Song, Sathish K R Padi, Libia A Luevano, et al.
Blood Reviews|March 16, 2024
Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?Geoffrey L Uy, Daniel J DeAngelo, Jay N Lozier, et al.
Leukemia|March 28, 2024
Molecular ontogeny underlies the benefit of adding venetoclax to hypomethylating agents in newly diagnosed AML patientsShai Shimony, Jacqueline S Garcia, Julia Keating, et al.
American Journal of Hematology|August 19, 2011
Chronic myeloid leukemia 2011: successes, challenges, and strategies--proceedings of the 5th annual BCR-ABL1 positive and BCR-ABL1 negative myeloproliferative neoplasms workshopTariq I Mughal, Jerald P Radich, Richard A Van Etten, et al.
Pageof 32